secwatch.observer — SEC 8-K summary
======================================

Issuer:     Adaptive Biotechnologies Corp (ADPT)
CIK:        0001478320
Form:       8-K
Filed at:   2026-06-09T20:30:16+00:00
Accession:  0001193125-26-263844
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Adaptive Biotechnologies annual meeting results: directors elected, say-on-pay approved, auditor ratified
--------------------------------------------------------------------------------

- Robert Hershberg elected Class I director with 71.81% of votes cast; 13.6M broker non-votes.
- Katey Owen elected Class I director with 97.72% of votes cast.
- Advisory vote on 2025 named executive officer compensation passed with 96.55% approval.
- Ratification of Ernst & Young as auditor for FY 2026 approved with 99.50% of votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1478320/000119312526263844/0001193125-26-263844-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1478320/000119312526263844/adpt-20260605.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-263844

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer